Tenax Therapeutics
TENX
23 hedge funds and large institutions have $27.9M invested in Tenax Therapeutics in 2016 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 1 closing their positions.
1,523% more call options, than puts
Call options by funds: $633K | Put options by funds: $39K
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
5% more funds holding
Funds holding: 22 → 23 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
9% less capital invested
Capital invested by funds: $30.6M → $27.9M (-$2.69M)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
+$473K |
| 2 |
BCM
Bourgeon Capital Management
Darien,
Connecticut
|
+$78.9K |
| 3 |
Creative Planning
Overland Park,
Kansas
|
+$78.9K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$78.9K |
| 5 |
Renaissance Technologies
New York
|
+$78.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$473K |
| 2 |
CA
Commerzbank Aktiengesellschaft
Frankfurt,
Germany
|
-$237K |
| 3 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$237K |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$204K |
| 5 |
AC
Armistice Capital
New York
|
-$158K |
TENX Hedge Fund Activity: Q3 2016 in Review
23 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q3 2016, worth a combined $27.9M — down 8.8% from $30.6M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new TENX positions and 1 closed out — a net gain of 1 holder — while 3 added to existing stakes and 4 trimmed.
The largest buyer was EverPoint Asset Management, adding an estimated $473K. The largest seller was Sabby Management, cutting an estimated $473K.
- 23 institutional investors held Tenax Therapeutics (TENX) as of Q3 2016, up from 22 in Q2 2016.
- Funds reported $27.9M of Tenax Therapeutics stock for Q3 2016, down 8.8% quarter-over-quarter.
- 2 funds opened new Tenax Therapeutics positions in Q3 2016 and 1 closed out, a net change of +1 holder.
- The largest Tenax Therapeutics buyer in Q3 2016 was EverPoint Asset Management, an estimated $473K added.
- The largest Tenax Therapeutics seller in Q3 2016 was Sabby Management, an estimated $473K sold.
Based on aggregated 13F filings for Q3 2016.